Carcinogenic evaluation of 2,3-dimethyl-2,3-dinitrobutane via the mouse skin bioassay.
T V Reddy, G R Olson, F B Daniel, M Robinson
Index: J. Appl. Toxicol. 14(3) , 231-2, (1994)
Full Text: HTML
Abstract
Female SENCAR mice initiated with 2,3-dimethyl-2,3-dinitrobutane (DMDNB) and promoted with 12-O-tetradecanoylphorol-13-acetate (TPA) via the SENCAR mouse skin bioassay did not exhibit a significant increase in skin tumors. The mice received 20 mg kg-1 DMDNB divided into six intragastric doses over 2 weeks and were promoted three times per week for 20 weeks.
Related Compounds
Related Articles:
Solid phase microextraction ion mobility spectrometer interface for explosive and taggant detection.
2005-02-01
[J. Sep. Sci. 28(2) , 177-83, (2005)]
2013-03-01
[J. Chromatogr. A. 1279 , 76-85, (2013)]
2007-05-28
[Inorg. Chem. 46(11) , 4422-9, (2007)]
Sensitive Voltammetric Sensing of the 2,3-Dimethyl-2,3-dinitrobutane (Dmnb) Explosive Taggant Wang JT, et al.
[Electroanalysis 18 , 971-975, (2006)]